Kelly Banas

Ph.D. Candidate

B.S. University of Delaware
MLS (ASCP)CM

Kelly Banas is a fourth-year graduate student at the University of Delaware with research interests in developing and evaluating novel gene editing strategies in non-small cell lung cancer. Her current focus is on targeting cancer specific NRF2 mutations with CRISPR gene editing tools and evaluating the short and long-term effects these specific targeting strategies have on affected and neighboring cells. Kelly’s seminal discovery of a unique CRISPR target site within tumor cells that is absent in normal cell surrounding the tumor, has established an innovative foundational approach to the treatment of solid tumors by CRISPR-directed gene editing. She recently been a major presentation to the FDA since her discoveries have enabled the development of a clinical protocol. She should receive her PhD in the spring of 2021.